Outcome of Neonates with Vein of Galen Malformation Presenting with Severe Heart Failure: A Case Series.


Journal

American journal of perinatology
ISSN: 1098-8785
Titre abrégé: Am J Perinatol
Pays: United States
ID NLM: 8405212

Informations de publication

Date de publication:
01 2019
Historique:
pubmed: 11 7 2018
medline: 16 4 2020
entrez: 11 7 2018
Statut: ppublish

Résumé

Neonatal presentation of vein of Galen aneurysmal malformations (VGAMs) complicated by cardiac failure and pulmonary hypertension is frequently associated with a poor prognosis. Interventional neuroradiology with embolization can offer a chance for survival, although neurological damage can represent a limitation. This article determines if aggressive intensive care and drug management of cardiac failure before urgent embolization can influence morbidity and mortality. Twelve infants (7 boys, 5 girls) were diagnosed with symptomatic vein of Galen malformations in the neonatal period during the period 2000 to 2014. Due to high output cardiac failure, endovascular treatment was attempted as soon as stabilization was achieved. Endovascular procedures successfully reverted cardiac failure in 5 patients who survived without significant neurological damage, while in 7 patients the causes of death were refractory cardiac failure, multiorgan failure, and severe brain damage. Bidimensional echocardiography assessment was performed at presentation and after early embolization procedures. Aggressive intensive care approach to heart failure and pulmonary hypertension leading to early neurointervention results in good survival rates with low morbidity even in cases of high-risk neonatal VGAM. Combined hemodynamic treatment can improve outcome in neonates with cardiac failure secondary to VGAM, although there is the risk of precipitating systemic hypoperfusion and renal failure. A moderate prematurity may not prevent both interventional approach and good outcome.

Sections du résumé

BACKGROUND
Neonatal presentation of vein of Galen aneurysmal malformations (VGAMs) complicated by cardiac failure and pulmonary hypertension is frequently associated with a poor prognosis. Interventional neuroradiology with embolization can offer a chance for survival, although neurological damage can represent a limitation.
OBJECTIVE
This article determines if aggressive intensive care and drug management of cardiac failure before urgent embolization can influence morbidity and mortality.
PATIENTS AND METHODS
Twelve infants (7 boys, 5 girls) were diagnosed with symptomatic vein of Galen malformations in the neonatal period during the period 2000 to 2014. Due to high output cardiac failure, endovascular treatment was attempted as soon as stabilization was achieved.
RESULTS
Endovascular procedures successfully reverted cardiac failure in 5 patients who survived without significant neurological damage, while in 7 patients the causes of death were refractory cardiac failure, multiorgan failure, and severe brain damage. Bidimensional echocardiography assessment was performed at presentation and after early embolization procedures.
CONCLUSION
Aggressive intensive care approach to heart failure and pulmonary hypertension leading to early neurointervention results in good survival rates with low morbidity even in cases of high-risk neonatal VGAM. Combined hemodynamic treatment can improve outcome in neonates with cardiac failure secondary to VGAM, although there is the risk of precipitating systemic hypoperfusion and renal failure. A moderate prematurity may not prevent both interventional approach and good outcome.

Identifiants

pubmed: 29991070
doi: 10.1055/s-0038-1666813
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

169-175

Informations de copyright

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Déclaration de conflit d'intérêts

None.

Auteurs

Gabriella De Rosa (G)

Department of Paediatric Cardiology, Catholic University "A. Gemelli" Hospital, Rome, Italy.

Maria Pia De Carolis (MP)

Neonatal Intensive Care Unit, Catholic University "A. Gemelli" Hospital, Rome, Italy.

Alessia Tempera (A)

Neonatal Intensive Care Unit, San Camillo-Forlanini Hospital, Rome, Italy.

Alessandro Pedicelli (A)

Department of Neuroradiology, Catholic University "A. Gemelli" Hospital, Rome, Italy.

Massimo Rollo (M)

Department of Neuroradiology, Catholic University "A. Gemelli" Hospital, Rome, Italy.

Tony Christian Morena (TC)

Paediatric Intensive Care Unit, Catholic University "A. Gemelli" Hospital, Rome, Italy.

Ersilia Luca (E)

Paediatric Intensive Care Unit, Catholic University "A. Gemelli" Hospital, Rome, Italy.

Daniele De Luca (D)

Neonatal Intensive Care Unit, Paris-Sud University Hospital, Paris, France.

Giorgio Conti (G)

Paediatric Intensive Care Unit, Catholic University "A. Gemelli" Hospital, Rome, Italy.

Marco Piastra (M)

Paediatric Intensive Care Unit, Catholic University "A. Gemelli" Hospital, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH